| Gene expression correlates of clinical prostate cancer behavior D Singh, PG Febbo, K Ross, DG Jackson, J Manola, C Ladd, P Tamayo, ... Cancer cell 1 (2), 203-209, 2002 | 3119 | 2002 |
| Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer EM Messing, J Manola, M Sarosdy, G Wilding, ED Crawford, D Trump New England Journal of Medicine 341 (24), 1781-1788, 1999 | 1499 | 1999 |
| mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways PK Majumder, PG Febbo, R Bikoff, R Berger, Q Xue, LM McMahon, ... Nature medicine 10 (6), 594-601, 2004 | 1138 | 2004 |
| Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy EM Messing, J Manola, J Yao, M Kiernan, D Crawford, G Wilding, ... The lancet oncology 7 (6), 472-479, 2006 | 1088 | 2006 |
| 6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial AV D'Amico, J Manola, M Loffredo, AA Renshaw, A DellaCroce, ... Jama 292 (7), 821-827, 2004 | 952 | 2004 |
| TP53 Mutations and Survival in Squamous-Cell Carcinoma of the Head and Neck ML Poeta, J Manola, MA Goldwasser, A Forastiere, N Benoit, JA Califano, ... New England journal of medicine 357 (25), 2552-2561, 2007 | 882 | 2007 |
| Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial CJ Langer, J Manola, P Bernardo, JW Kugler, P Bonomi, D Cella, ... Journal of the National Cancer Institute 94 (3), 173-181, 2002 | 657 | 2002 |
| Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial NB Haas, J Manola, RG Uzzo, KT Flaherty, CG Wood, C Kane, M Jewett, ... The Lancet 387 (10032), 2008-2016, 2016 | 651 | 2016 |
| A pooled analysis of eastern cooperative oncology group and intergroup trials of adjuvant high-dose interferon for melanoma JM Kirkwood, J Manola, J Ibrahim, V Sondak, MS Ernstoff, U Rao Clinical Cancer Research 10 (5), 1670-1677, 2004 | 646 | 2004 |
| Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer CL Shapiro, J Manola, M Leboff Journal of Clinical Oncology 19 (14), 3306-3311, 2001 | 563 | 2001 |
| Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer HJ Burstein, I Kuter, SM Campos, RS Gelman, L Tribou, LM Parker, ... Journal of Clinical Oncology 19 (10), 2722-2730, 2001 | 536 | 2001 |
| The telomerase reverse transcriptase regulates chromatin state and DNA damage responses K Masutomi, R Possemato, JMY Wong, JL Currier, Z Tothova, JB Manola, ... Proceedings of the national academy of sciences 102 (23), 8222-8227, 2005 | 492 | 2005 |
| Her-2-neu expression and progression toward androgen independence in human prostate cancer S Signoretti, R Montironi, J Manola, A Altimari, C Tam, G Bubley, S Balk, ... Journal of the National Cancer Institute 92 (23), 1918-1925, 2000 | 479 | 2000 |
| Prognostic factors in metastatic melanoma: a pooled analysis of Eastern Cooperative Oncology Group trials J Manola, M Atkins, J Ibrahim, J Kirkwood Journal of Clinical Oncology 18 (22), 3782-3793, 2000 | 447 | 2000 |
| Phase III study of interferon alfa-NL as adjuvant treatment for resectable renal cell carcinoma: an Eastern Cooperative Oncology Group/Intergroup trial EM Messing, J Manola, G Wilding, K Propert, J Fleischmann, ED Crawford, ... Journal of clinical oncology 21 (7), 1214-1222, 2003 | 384 | 2003 |
| Phase II and pharmacokinetic study of ecteinascidin 743 in patients with progressive sarcomas of soft tissues refractory to chemotherapy R Garcia-Carbonero, JG Supko, J Manola, MV Seiden, D Harmon, ... Journal of clinical oncology 22 (8), 1480-1490, 2004 | 368 | 2004 |
| Adjuvant active specific immunotherapy for stage II and III colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Group Study E5283 JE Harris, L Ryan, HC Hoover Jr, RK Stuart, MM Oken, AB Benson III, ... Journal of Clinical Oncology 18 (1), 148-148, 2000 | 337 | 2000 |
| Docetaxel administered on a weekly basis for metastatic breast cancer HJ Burstein, J Manola, J Younger, LM Parker, CA Bunnell, R Scheib, ... Journal of Clinical Oncology 18 (6), 1212-1219, 2000 | 332 | 2000 |
| Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer MJ Fisch, JW Lee, M Weiss, LI Wagner, VT Chang, D Cella, JB Manola, ... Journal of Clinical Oncology 30 (16), 1980, 2012 | 309 | 2012 |
| Phase II randomized study of vaccine treatment of advanced prostate cancer (E7897): a trial of the Eastern Cooperative Oncology Group HL Kaufman, W Wang, J Manola, RS DiPaola, YJ Ko, C Sweeney, ... Journal of Clinical Oncology 22 (11), 2122-2132, 2004 | 305 | 2004 |
